Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001641172-25-013148
Filing Date
2025-05-30
Accepted
2025-05-30 20:00:11
Documents
1
Period of Report
2025-05-28

Document Format Files

Seq Description Document Type Size
1 ownership.html 4  
1 ownership.xml 4 6867
  Complete submission text file 0001641172-25-013148.txt   8320
Mailing Address 100 SE 2ND ST SUITE 2000 #1009 MIAMI FL 33131
Business Address 100 SE 2ND ST SUITE 2000 #1009 MIAMI FL 33131 786-396-6723
Telomir Pharmaceuticals, Inc. (Issuer) CIK: 0001971532 (see all company filings)

EIN.: 872606031 | State of Incorp.: FL | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O MIRA PHARMACEUTICALS, INC. 900 WEST PLATT STREET, SUITE 200 TAMPA FL 33606-2173
Business Address
Aminov Erez (Reporting) CIK: 0001986112 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-41952 | Film No.: 251012816